Nephrotoxicity induced by vascular endothelial growth factor inhibitors
Vascular endothelial growth factor (VEGF) is a special mitogen for vascular endothelial cells, an essential endogenous angiogenic cytokine, and the principal controller of vascular growth that plays a fundamental role in therapeutic angiogenesis pathways. VEGF-targeted therapy is categorized into th...
Main Authors: | Shirinsadat Badri, Lillian Siberian, Rasool Soltani, Azadeh Moghaddas, Sara Ataei, Mahnaz Momenzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2022-01-01
|
Series: | Journal of Nephropharmacology |
Subjects: | |
Online Access: | https://jnephropharmacology.com/PDF/npj-10435 |
Similar Items
-
Diagnostic thinking of renal capillary endothelial cell hyperplasia
by: Lü Guangna, Yan Yu
Published: (2023-08-01) -
Association of Novel Advanced Glycation End-Product (AGE10) with Complications of Diabetes as Measured by Enzyme-Linked Immunosorbent Assay
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2021-09-01) -
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
by: Eleni Gavriilaki, et al.
Published: (2022-06-01) -
Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
by: Losa-Rodríguez Rita, et al.
Published: (2020-11-01) -
Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)